老年人的功能健康基准值:系统性审查
Marco Cossio-Bolaños1,2, Ruben Vidal-Espinoza3, Ignacio Villar-Cifuentes1
1Departamento de Ciencias de la Actividad Física, Universidad Católica del Maule, Talca, Chile.
Frontiers in public health
|April 5, 2024
概括
这次审查确定了60岁以上成年人使用的高级健身测试 (SFT) 的身体测试. 规范值显示,随着年龄的增长,功能适应性下降,男性的表现通常优于女性.
科学领域:
- 老年学和运动科学
- 公共卫生与老龄化问题
- 生物医学研究生物医学研究
背景情况:
- 功能性健身对于成人健康和福祉至关重要.
- 规范性价值和标准对于评估功能适应性至关重要.
- 高级健身测试 (SFT) 是广泛用于评估老年人的身体健康的工具.
研究的目的:
- 为了从自成立以来应用的高级健身测试 (SFT) 中识别身体测试.
- 描述基于年龄,性别和国家的SFT组件的拟议百分位数.
- 综合现有的关于老年人功能健康的规范性数据.
主要方法:
- 对Pubmed和Scopus数据库进行了系统审查.
- 包括在1999年至2022年间发表的研究,重点关注60岁以上的个人,并通过百分位数报告SFT规范值.
- MeSH术语包括"身体健康"",运动测试"",高级健康测试"",功能健康"",心肺健康"",老年人"",年龄"和"参考标准".
主要成果:
- 从五个国家 (中国,波兰,葡萄牙,西班牙,美国) 确定了七项研究,涵盖60-103岁的年龄段.
- 没有关于所有八个SFT组件的研究报告;规范值以百分点分布 (p10,p50,p90) 呈现,按年龄组划分.
- 与所有评估组件的女性相比,男性在功能性身体健康 (FPF) 测试中总体表现优越.
结论:
- 高级健身测试 (SFT) 已在多个国家应用,但没有一项研究公布了完整测试数据.
- 现有的规范性数据表明,随着年龄的增长,功能适应性下降.
- 需要进行进一步的研究,以建立SFT的全面和全球代表性的规范价值.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...